Organizational Chart International Technology Transfer General Information Career Opportunities


Spacer

 
Licensing & Royalties
spacer
 

Licensing Opportunities

Technology Abstracts

Print This Abstract Apply Questions ?
Method of Assessing Ischemia in a Patient

Description of Invention:
Hyperintense acute reperfusion marker (HARM) is well correlated with reperfusion and is a precursor to or concomitant with reperfusion injury. The inventors have developed a novel technique of assessing injuries associated with ischemia, stroke, or reperfusion injury in a patient by administering a contract agent to the patient, acquiring a fluid-attenuated inversion-recovery (FLAIR) image, and observing the presence or absence of HARM on the acquired image. The technique can also be used to determine the effectiveness of a therapeutic protocol for the treatment or prevention of reperfusion injury in a patient that has previously suffered an ischemic event.

Inventors:
Steven Warach and Lawrence Latour (NINDS)

Patent Status:
DHHS Reference No. E-082-2002/0-US-01 filed 17 Mar 2002 (U.S. Provisional Application No. 60/381,611)
DHHS Reference No. E-082-2002/0-PCT-02 filed 16 May 2003 (PCT Application No. PCT/US03/15368)

Relevant Publication: This research has been described, in part, in Latour et al., “Early Blood-Brain Barrier Disruption in Human Focal Brain Ischemia,” Ann. Neurol. 2004 56:568-477.


Portfolios:
Devices/Instrumentation

Devices/Instrumentation-Diagnostics-Physical Medicine
Devices/Instrumentation-Diagnostics-Instruments
Devices/Instrumentation-Diagnostics-Imaging
Devices/Instrumentation-Diagnostics


For Additional Information Please Contact:
Michael Shmilovich J.D.
NIH Office of Technology Transfer
6011 Executive Blvd, Suite 325
Rockville, MD 20852-3804
Phone: (301) 435-5019
Email: shmilovm@mail.nih.gov
Fax: (301) 402-0220


Web Ref: 733

Updated: 11/04

 

 
 
Spacer